Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Catalyst" is a fundamental biochemical term referring to a substance that increases the rate of a chemical reaction without undergoing any permanent chemical change itself. In the human body, the vast majority of biological catalysts are enzymes, which represent one of the most significant classes of therapeutic targets, including kinases, proteases, and polymerases [6, 11, 15]. While many specific targets function as catalysts, "Catalyst" is not a canonical name for a single protein, receptor, or gene. Instead, it serves as a functional classification for molecules that facilitate essential processes such as metabolism, signal transduction, and DNA replication [10, 11, 14]. The term is frequently encountered in the biotechnology sector within company names (e.g., Catalyst Pharmaceuticals, Catalyst Biosciences) or as a descriptive label for proteins like Protein Disulfide Isomerase (a protein-folding catalyst) or Atlastin-3 (a membrane fusion catalyst) [7, 8, 19]. It is also the name of established drug discovery software platforms, such as Accelrys Catalyst, used for pharmacophore modeling and virtual screening [8, 11]. Because "Catalyst" lacks specificity for a single molecular entity, it cannot be characterized by a unique set of interacting drugs or disease roles without reference to a specific enzymatic target. Analysts should identify the specific protein or enzyme (e.g., Catalase, Caspase-1, or a specific kinase) to obtain valid structured target information.
Not applicable as "Catalyst" is a broad functional category rather than a specific molecular target. In biological systems, catalysts (primarily enzymes) lower the activation energy of reactions to facilitate physiological processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Catalyst.